#Germany #Aurora Cannabis #Edmonton #medical cannabis #Daily Special

Aurora Cannabis Empowers Patients with Daily Special™ in Germany

On December 18, 2025, Aurora Cannabis Inc., a premier global medical cannabis company based in Canada, unveiled its latest innovation, the Daily Special™, tailored specifically for the German market. This launch not only represents an expansion of Aurora's formidable portfolio but also aims to provide patients with high-quality, affordable medical cannabis.

The Daily Special™ is designed to meet the increasing demand in Germany’s flourishing medical cannabis sector. Andreas Dotterweich, Senior Vice President at Aurora Europe, remarked on this significant development, stating, "The introduction of Daily Special in Germany highlights our long-term investment strategy and leadership within one of the globe’s most pivotal medical cannabis markets. As an industry leader, we are perfectly poised to introduce a brand that resonates deeply with patients and further fosters the growth of Germany's medical cannabis landscape."

Aurora’s Daily Special™ will be available in German pharmacies and through telemedicine platforms starting December 19, 2025. The product features a sativa-dominant strain resulting from a unique crossbreed of Gelonade × Biscotti, boasting THC levels between 21% and 23% and less than 1% CBD. Users can expect an exciting olfactory experience characterized by vibrant citrus notes and a sweet-earthy undertone, complemented by diesel-forward aromas that define its distinctiveness and premium quality.

Aurora’s expansive genetic library and commitment to quality set the company apart from competitors as it supports the burgeoning German market. The company has effectively established itself as a vital player by enhancing patient access and advocating for innovative growth strategies within emerging markets.

With the European cannabis market projected to expand significantly, Aurora's introduction of Daily Special™ positions the company to capitalize on this uptick. Not only is this a pivotal time for the company, but it also marks a milestone for patients seeking dependable cannabis solutions.

Aurora Cannabis has been a trailblazer in the global cannabis scene, aiming to improve lives through its various product offerings. Alongside the Daily Special™, Aurora continues to innovate across its brand portfolio, which includes recognized names such as Drift®, MedReleaf®, and more. The central ethos of the company remains rooted in science and innovation, establishing a standard for excellence in the medical, wellness, and adult recreational markets.

As the demand for medical cannabis rises, the introduction of Daily Special™ is expected to set a new benchmark in terms of affordability and quality. Aurora's commitment to GMP production standards further assures users of compliance with the highest industry regulations, providing peace of mind when accessing medical cannabis.

In conclusion, Aurora Cannabis’s launch of Daily Special™ is not merely an expansion of its product line but also a vital step toward improving patient access to medical cannabis in Germany. This evolution reflects a broader trend within the medical cannabis industry, as companies increasingly recognize the necessity of high-quality, affordable choices for consumers. Aurora's initiative will likely resonate with patients and play a crucial role in shaping the future of cannabis in Germany.